Molecular Biology of Osteosarcoma.
Czarnecka AM, Synoradzki K, Firlej W, Bartnik E, Sobczuk P, Fiedorowicz M, Grieb P, Rutkowski P. · 2020
Read Molecular Biology of Osteosarcoma. by Czarnecka AM, Synoradzki K, Firlej W, Bartnik E, Sobczuk P, Fiedorowicz M, Grieb P, Rutkowski P. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7463657.txt.
Description
Czarnecka and co-authors review the molecular biology of osteosarcoma, a bone cancer of the young. It is the most common primary bone cancer in children and teens. Inherited syndromes can raise its risk.
The gene TP53 is the most often altered gene in this cancer. The RB gene also shows frequent changes, above all in children. Other driver changes hit genes such as NOTCH1, FOS, NF2, and BRCA2. Small RNAs tune key growth pathways in the tumor cells. Some tumor cells act like stem cells and may seed spread and drug resistance. Care still rests on chemotherapy and surgery. New targeted drugs, such as cabozantinib and sorafenib, are in study. The review maps genes, pathways, and treatment leads.
Catalog record
| CREATOR | Czarnecka AM, Synoradzki K, Firlej W, Bartnik E, Sobczuk P, Fiedorowicz M, Grieb P, Rutkowski P. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 97 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |